课题基金 / 基金详情

Gene editing of cultured plant stem cells to biomanufacture sustainable phytochemicals

Gene editing of cultured plant stem cells to biomanufacture sustainable phytochemicals
对培养的植物干细胞进行基因编辑以生物制造可持续的植物化学物质
批准号:
2886001
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这个BBSRC工业案例奖学金是联合利华公司,爱丁堡大学和绿色生物活性有限公司之间的合作。成功的申请人将主要位于爱丁堡大学分子植物科学研究所,但也可能在联合利华公司进行研究,获得尖端的商业和研究技能。该奖学金将为培养的植物干细胞开发新的转化和相关的基因编辑技术,以帮助提高个人护理产品的天然和潜在可持续成分的产量。这项工作将有助于建立一个可持续和可靠的基于植物细胞的生物制造平台,用于未来生产一种关键成分,以及可能的其他相关植物天然产品,以帮助满足全球个人护理需求。这种工业-学术合作提供了一个独特的机会来发展商业和学术研究技能的融合,为未来的职业发展提供了坚实的基础。将通过年度学生研讨会、虚拟会议、特定培训课程和数字通信,大力鼓励和促进联合利华BBSRC CASE学生群体的网络联系。
英文摘要
This BBSRC Industrial CASE studentship is a collaboration between Unilever Plc, the University of Edinburgh and Green Bioactives Ltd. The successful applicant will be predominantly located at the Institute of Molecular Plant Sciences, University of Edinburgh but may also undertake research at Unilever Plc acquiring cutting-edge commercial and research skills. The Studentship will develop novel transformation and associated gene editing technologies for cultured plant stem cells to help improve yields of a natural and potentially sustainable ingredient for personal care products. This work will help facilitate the establishment of a sustainable and reliable plant cell-based biomanufacturing platform for the future production of a key ingredient, and potentially other related plant natural products, to help meet global personal care needs. This industrial-academic collaboration provides a unique opportunity to develop a blend of commercial and academic research skills, providing a strong basis for future career development. Networking across the Unilever BBSRC CASE student cohort will be strongly encouraged and facilitated through the annual student workshop, virtual meeting, specific training courses and digital communications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于prime editing基因编辑小鼠造血干细胞治疗重症联合免疫缺陷的研究
先导编辑技术(prime editing)在双子叶植物中的优化
prime editing基因编辑技术靶向修复MYD88突变治疗华氏巨球蛋白血症的作用及机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    王欣
  • 依托单位:
先导编辑技术(prime editing)在双子叶植物中的优化